Business

Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market

Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion. 

adminadmin
Aug 1, 2024 - 19:00
 0  4
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion. 
Read More

Tags:

Previous Article

U.S. rugby star Ilona Maher says Olympic bronze medal may have saved the team

Next Article

Stocks making the biggest moves premarket: Hershey, Meta Platforms, Arm Holdings...

admin
admin

Related Posts

Fathom, the company behind classic films at your local theater, is making major gains in moviegoing

Fathom, the company behind classic films at your local ...

admin Jul 1, 2024  0  4

Stocks making the biggest moves midday: Workday, Lucid, Toast, Deckers and more

Stocks making the biggest moves midday: Workday, Lucid,...

admin May 25, 2024  0  13

Fed’s key inflation gauge rose 2.5% in June from a year ago, in line with expectations

Fed’s key inflation gauge rose 2.5% in June from a year...

admin Jul 26, 2024  0  10